x
Filter:
Filters applied
- Protein Synthesis and Degradation
- Day, RobertRemove Day, Robert filter
- Essalmani, RachidRemove Essalmani, Rachid filter
Keyword
- anticoagulant serine pro1
- furin1
- glypican-31
- hepatocyte1
- HepG2 cells1
- knockdown1
- LDL receptor (LDLR)1
- lentivirus1
- liver1
- low density lipoprotein (LDL)1
- mass spectrometry (MS)1
- proprotein convertase1
- proprotein convertase subtilisin/kexin type 9 (PCSK9)1
- protein C1
- secretome1
- serine protease1
- short hairpin RNA (shRNA)1
- thrombin1
- thrombin activation1
- vitamin K1
Protein Synthesis and Degradation
2 Results
- Protein Synthesis and DegradationOpen Access
Thrombin activation of protein C requires prior processing by a liver proprotein convertase
Journal of Biological ChemistryVol. 292Issue 25p10564–10573Published online: June 23, 2017- Rachid Essalmani
- Delia Susan-Resiga
- Johann Guillemot
- Woojin Kim
- Vatsal Sachan
- Zuhier Awan
- and others
Cited in Scopus: 7Protein C, a secretory vitamin K-dependent anticoagulant serine protease, inactivates factors Va/VIIIa. It is exclusively synthesized in liver hepatocytes as an inactive zymogen (proprotein C). In humans, thrombin cleavage of the propeptide at PR221↓ results in activated protein C (APC; residues 222–461). However, the propeptide is also cleaved by a furin-like proprotein convertase(s) (PCs) at KKRSHLKR199↓ (underlined basic residues critical for the recognition by PCs), but the order of cleavage is unknown. - Cell BiologyOpen Access
An Unbiased Mass Spectrometry Approach Identifies Glypican-3 as an Interactor of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) and Low Density Lipoprotein Receptor (LDLR) in Hepatocellular Carcinoma Cells
Journal of Biological ChemistryVol. 291Issue 47p24676–24687Published online: October 7, 2016- Kévin Ly
- Rachid Essalmani
- Roxane Desjardins
- Nabil G. Seidah
- Robert Day
Cited in Scopus: 10The mechanism of LDL receptor (LDLR) degradation mediated by the proprotein convertase subtilisin/kexin type 9 (PCSK9) has been extensively studied; however, many steps within this process remain unclear and still require characterization. Recent studies have shown that PCSK9 lacking its Cys/His-rich domain can still promote LDLR internalization, but the complex does not reach the lysosome suggesting the presence of an additional interaction partner(s). In this study we carried out an unbiased screening approach to identify PCSK9-interacting proteins in the HepG2 cells' secretome using co-immunoprecipitation combined with mass spectrometry analyses.